Mostrar el registro sencillo del ítem
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
dc.contributor.author | Estupiñán Sánchez, Óscar Rafael | |
dc.contributor.author | Rey, Verónica | |
dc.contributor.author | Tornín, Juan | |
dc.contributor.author | Murillo, D. | |
dc.contributor.author | Gallego, B. | |
dc.contributor.author | Huergo, C. | |
dc.contributor.author | Blanco Lorenzo, V. | |
dc.contributor.author | González Meana, María Victoria | |
dc.contributor.author | Rodríguez, A. | |
dc.contributor.author | Moris, F. | |
dc.contributor.author | González, J. | |
dc.contributor.author | Ayllón, V. | |
dc.contributor.author | Ramos Mejía, V. | |
dc.contributor.author | Bigas, A. | |
dc.contributor.author | Rodríguez, R. | |
dc.date.accessioned | 2023-06-26T09:03:09Z | |
dc.date.available | 2023-06-26T09:03:09Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Biomedicine and Pharmacotherapy, 162 (2023); doi:10.1016/j.biopha.2023.114627 | |
dc.identifier.issn | 0753-3322 | |
dc.identifier.uri | http://hdl.handle.net/10651/68549 | |
dc.description.sponsorship | This work was supported by the Agencia Estatal de Investigación (AEI) [MICINN/Fondo Europeo de Desarrollo Regional (FEDER) (grant PID2019–106666RB-I00 to R.R.) and ISCIII/FEDER (Consorcio CIBERONC - CB16/12/00390)] and the Plan de Ciencia Tecnología e Innovación del Principado de Asturias/FEDER [grant IDI/2021/000027 and Severo Ochoa predoctoral fellowships BP-17–108 to O.E., BP20–046 to B.G. and BP-21–084 to DM]. | |
dc.language.iso | eng | |
dc.relation.ispartof | Biomedicine and Pharmacotherapy | |
dc.rights | © 2023 The authors. Published by Elsevier Masson SAS | |
dc.rights | CC Reconocimiento 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85151414289&doi=10.1016%2fj.biopha.2023.114627&partnerID=40&md5=4d4a70ab26e3ee400e8ff362e73a99f4 | |
dc.title | Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling | |
dc.type | journal article | |
dc.identifier.doi | 10.1016/j.biopha.2023.114627 | |
dc.relation.projectID | MICINN/FEDER/PID2019–106666RB-I00 | |
dc.relation.projectID | ISCIII/FEDER/CB16/12/00390 | |
dc.relation.projectID | FICYT/FEDER/IDI/2021/000027 | |
dc.relation.projectID | Severo Ochoa/BP-17–108 | |
dc.relation.projectID | Severo Ochoa/BP20–046 | |
dc.relation.projectID | Severo Ochoa/BP-21–08 | |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.biopha.2023.114627 | |
dc.rights.accessRights | open access | |
dc.type.hasVersion | VoR |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [36307]
-
Cirugía y Especialidades Médico Quirúrgicas [298]
-
Investigaciones y Documentos OpenAIRE [7936]
Publicaciones resultado de proyectos financiados con fondos públicos